UDOW ranks 2nd and CURE 7th of 30 funds in the 3x Leveraged Long Category.
CURE vs UDOW
Same figure. Both funds show the same value, so neither comes out ahead.
0.94%0.94%
UDOW 26.7×the volume
64.4K1.72M
UDOW +0.8pt
+21.5%+22.3%
CURE vs UDOW Performance
+43.1%+66.5%
- CURE 0.94%
- UDOW 0.94%
- CURE $199M
- UDOW $841M
- CURE +84.6%, better
- UDOW +16.0%
- CURE 0.75%
- UDOW 1.06%, better
- CURE 67
- UDOW 33
- CURE 64.4K sh
- UDOW 1.72M sh, better
- CURE $165.72
- UDOW $65.43
ETF.net Grade
| Pillar | CURE | UDOW |
|---|---|---|
| Cost | A78 | A78 |
| Mission | A77 | |
| Risk | A75 | A85Higher |
| Tradability | B58 | A89Higher |
| Holdings | B56 | |
| Durability | C53 | A71Higher |
Rank among 3x Leveraged Long funds
Same Category. CURE and UDOW are both graded against the same 30 3x Leveraged Long funds, so their Grades compare head to head.
Our read on each fund
CUREA
UDOWA
In short
CURE Healthcare is the market's defensive sector. CURE straps three-times daily leverage to it, aiming for 300% of the Health Care Select Sector Index's daily move across drugmakers, insurers and device names. A trading tool with a one-day clock, running since 2011.
UDOW The only 3x daily play on the Dow: 30 blue-chip names, price-weighted, reset every session. It is the industrial cousin of the semis-and-Nasdaq crowd that fills the leveraged aisle, and it has run since 2010.
Stated mandate
CURE The fund seeks daily investment results, before fees and expenses, equal to 300% of the performance of the Health Care Select Sector Index.
UDOW The Fund seeks daily results equal to three times the daily performance of the Dow Jones Industrial Average before fees and expenses. It uses equity securities, derivatives, and money-market instruments to pursue that daily leveraged exposure.
Why people hold it
Worth knowing
CURE vs UDOW Holdings
How we measure overlap
Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.
CURE vs UDOW Cost
Same expense ratio
$17,704
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
CURE 0.94%
$17,704
UDOW 0.94%
$17,704
Cost over time
Year by year
| Year | CURE | UDOW |
|---|---|---|
| 10 | $1,661 | $1,661 |
| 20 | $6,260 | $6,260 |
| 30 | $17,704 | $17,704 |
- 0.94%CURE
- 0.94%UDOW
- Middle half of 3x Leveraged Long funds
- Median 0.96%
CURE 7th cheapest of 30 funds
UDOW 7th cheapest of 30 funds
CURE vs UDOW Dividends
- CURE 0.75%
- UDOW 1.06%, better
- CURE $1.26
- UDOW $0.69
- CURE $0.32
- UDOW $0.15
- CURE Sep 22, 2026
- UDOW Sep 23, 2026
- CURE Sep 29, 2026
- UDOW Sep 29, 2026
- CURE Quarterly
- UDOW Quarterly
Distribution history
CURE vs UDOW Risk
Fall from peak · 5 years
- CURE
- UDOW
Risk facts
- Volatility
- CURE 44.6%UDOW 37.2%, better
- Return per unit of risk
- CURE 0.71UDOW 0.95, better
- Worst fall
- CURE −52.3%, betterUDOW −56.0%
- Market sensitivity
- CURE 1.27UDOW 2.62
Popular comparisons
- 0.94% · 0.78%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.94% · 0.78%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.94% · 0.88%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.94% · 0.88%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.94% · 0.75%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.94% · 0.75%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.